Welcome international healthcare professionals

This site is no longer supported and will not be updated with new content. You are welcome to browse and download all content already included in the site. Please note you will have to register your email address to access the site.

You are here

Reinhard Dummer

Reinhard Dummer (University Hospital of Zurich, Switzerland) discusses new trial data presented at ESMO 2012

BRAF inhibitors, MEK inhibitors and immunotherapies are transforming the landscape in melanoma treatment. Resource Centre Editor, Reinhard Dummer (University Hospital of Zurich, Switzerland) discusses new trial data presented at ESMO 2012, and explains to Helen Saul, EJC news editor, why the recent advances are important, not just in improving outcomes for patients now, but also in generating the knowledge, the interest and the optimism which are likely to lead to further success in future.

Share

 

 

E-Alert

Register to our E-Alert to stay informed of new clinical research and cases published on this platform.

Search this site

Search form

EJC SOCIETY PARTNERS